Published Sep 24, 2026, 7:43 PM ET · Updated 2 months ago · 2 sources

Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO

bloomberg

Original Report

Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.